Theravance Biopharma Inc.

8.61
0.01 (0.17%)
At close: Apr 17, 2025, 3:59 PM
8.62
0.12%
After-hours: Apr 17, 2025, 04:02 PM EDT

Theravance Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
37.8M 39.55M 298.17M 89.96M 81.47M 58.06M 378.02M 88.98M 344.71M
50.55M 62.88M 29.31M 83.51M 211.47M 222.77M 127.25M 259.59M 156.39M
n/a n/a 836K 67.54M 12.75M 4.99M 11.87M 41.59M 91.56M
157.32M 203.1M 201.1M 4.07M 3.28M 6.11M 2.37M 10.91M 10.73M
68.44M 17.47M 16.79M 57.6M 69.67M n/a 10.67M 9.36M 9.72M
n/a n/a 1.51M 10.24M 20.37M 1.00 1.00 16.83M 12.22M
4.2M 11.6M 7.68M 8.56M 10.36M 57.66M n/a 3.7M 2.4M
161.07M 133.54M 353.46M 249.87M 393.34M 338.49M 532.82M 378.75M 528.5M
35.77M 45.35M 52M 53.35M 59.68M 59.25M 13.18M 10.16M 8.46M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
193.09M 248.46M 253.94M 124.95M 75.72M 70.34M 27.41M 62.65M 110.75M
354.16M 382M 607.4M 374.82M 469.06M 408.83M 560.24M 441.4M 639.25M
2.24M 1.52M 1.55M 3.1M 6.78M 4.76M 9.03M 5.92M 1.73M
n/a n/a 24K 98K 11.52M 31.57M 43.4M 125K 152K
10.71M n/a n/a 16.94M 19.33M 17.61M n/a n/a n/a
19.13M 12.88M 10.07M 50.3M 81.67M 29.58M 22.32M 32.37M 33.36M
32.09M 24.77M 28.71M 58.59M 123.57M 111.7M 98.55M 62.55M 49.27M
39.11M n/a 45.41M 599.39M 599.84M 445.19M 454.35M 223.75M 222.68M
107.42M 99M 45.88M 2.42M 1.83M 21.29M 32.74M 39.92M 17.08M
146.53M 144.24M 136.88M 654.8M 649.24M 520.96M 513.27M 263.67M 239.75M
178.62M 169M 165.6M 713.39M 772.81M 632.67M 611.82M 326.22M 289.02M
49.82M 49.16M 74.12M 652.08M 647.06M 492.92M 454.35M 223.75M 222.68M
n/a n/a 1K 1K 1K 1K 1K 1K 1K
-965.52M -909.1M -853.91M -1.73B -1.53B -1.25B -1.01B -797.74M -512.23M
7K -65K -15K -0.00 47K 145K -166K -733K -253K
175.54M 213M 441.8M -338.57M -303.75M -223.84M -51.59M 115.18M 350.23M
50.55M 62.88M 29.31M 151.04M 224.22M 227.75M 139.12M 301.17M 255.95M